Zantac

If you or someone you know frequently used Zantac, whether for chronic heartburn relief or occasional discomfort, it’s crucial to understand the risks. Recent findings have linked this once-common medication to certain types of cancer due to an impurity present in the drug.

You might be entitled to significant compensation.

Courts have recently determined that the carcinogenic compound NDMA, found in Zantac, is associated with specific cancer forms. Stand up for your rights and the health of your loved ones. Reach out to us today, and let’s explore your potential claim together.

FDA Issues a Recall of All Zantac Products

In April 2020, the FDA recalled all forms of Zantac, including prescription and over-the-counter versions, due to alarmingly high levels of the harmful compound NDMA. Urging patients to cease using ranitidine, the FDA also asked manufacturers to halt the production and recall both branded and generic versions of the drug. Even before this directive, several retailers and companies like CVS, Walmart, and Sandoz had proactively suspended Zantac sales pending further research outcomes.


Zantac Manufacturers Identified in Several Lawsuits

Manufacturers like Sanofi-Aventis U.S. LLC, Sanofi U.S. Services Inc., Chattem Inc., Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are implicated in various lawsuits concerning the brand name Zantac. However, in July 2021, due to federal legal protections, Judge Robin L. Rosenberg ruled to dismiss cases against generic drug producers such as Teva Pharmaceuticals and Amneal Pharmaceuticals.


Contact a Zantac Lawsuit Attorney

If you have been affected due to Zantac exposure, we urge you to file a claim. We have experienced lawyers ready to guide you through the process.

Get in touch today to take your first step towards compensation and peace of mind.

See if You Qualify for Compensation

Please enable JavaScript in your browser to complete this form.